KLRK1 and cancer: This article discusses the role of epigenetic modifications that regulate the expression of activating NKG2D ligands and reviews various clinical trials with NK cells, highlighting the effectiveness of NK cell-based immunotherapy as a successful and promising therapeutic strategy for cancer treatment.